(a) (i) As on 02 December 2022 a total of 48 claims were received.
(ii)(aa)-(bb) To date none of the claims were assessed.
(b) (i) The adjudication panel has been appointed and assessments of claims will be conducted.
(b)(ii) |
Types of vaccines administered |
Age groups of people affected |
||
(aa) |
(bb) |
|||
Johnson & Johnson |
Pfizer |
Age group |
Number |
|
21 |
27 |
80+ |
3 |
|
70-79 |
2 |
|||
60-69 |
11 |
|||
50-59 |
8 |
|||
40-49 |
9 |
|||
30-39 |
2 |
|||
20-29 |
7 |
|||
12-19 |
6 |